FDA OKs new drug for heavy periods

Lysteda approved as first non-hormonal way to reduce menstrual bleeding

Women's health videos

Mammography guidelines 'misunderstood'
Dec. 2: As a national gathering of radiologists fiercely attacked highly controversial mammography recommendations Tuesday, the head of the task force that released the guidelines told a Congressional panel its message was widely misunderstood. NBC Chief Science Correspondent Robert Bazell reports.

Experts clarify mammogram recommendations

Down syndrome rising in U.S.

Abortion causing a generational rift?

When only a baby girl will do

updated 4:36 p.m. ET Nov. 13, 2009

WASHINGTON - Federal health officials have approved a new drug as the first non-hormonal treatment for heavy menstrual bleeding.

The Food and Drug Administration says Lysteda tablets reduce bleeding by acting on a protein that helps blood clot. The drug is made by Newport, Ky.-based Xanodyne Pharmaceuticals.

The main ingredient in the drug was first approved in 1986 as an injection for patients with hemophilia, an inheritable disease that prevents blood clotting.

Story continues below ↓

advertisement | your ad here

The FDA warns that taking Lysteda with hormonal contraceptive drugs can increase the risk of blood clots, stroke and heart attacks. Women should only use the products together if there is a strong medical need, the agency says.

Also in msnbc.com Health
Dark shadows loom over ‘facilitated’ talk
Loneliness can be contagious, study finds
Cat food recalled over thiamin deficiency
7 items you didn't know were in health bill
Animal Tracks: Eye candy for animal lovers